upadacitinib
abbvie
['upadacitinib', 'crohn']
 presenting the #upadacitinib maintenance data from the u-endure study in crohn s disease impressive maintenance data
seems 30 mg dose numerically better in favorable outcomes compared to 15 mg with slightly higher rates of hz #acg2022 
Gastroenterologist, IBD specialist @yaledigestive. A @mayoclinic alumnus. Tweets are my own.